Loading chat...
KS HB2364
Bill
Status
2/18/2026
Primary Sponsor
Health and Human Services
Click for details
AI Summary
-
Prohibits health insurers from denying coverage of nonopioid pain medications in favor of opioids or requiring patients to try opioids first before covering nonopioid alternatives
-
Applies to Kansas Medicaid, the state children's health insurance program (CHIP), and the state employee health benefits plan, including their managed care organizations
-
Requires that FDA-approved nonopioid pain drugs receive coverage and cost-sharing terms at least as favorable as opioid/narcotic drugs on the insurer's formulary
-
Bans placing nonopioid pain drugs on higher cost-sharing tiers than opioids, and prohibits more restrictive prior authorization or step therapy requirements for nonopioids compared to opioids
-
Permits insurers to prefer certain opioids over other opioids and certain nonopioids over other nonopioids within each drug category
Legislative Description
Prohibiting certain health insurers from requiring cost-sharing for nonopioid prescription drugs or providing less favorable coverage for such drug than that for opioid or narcotic prescription drugs for the treatment of pain.
Last Action
Senate Referred to Committee on Public Health and Welfare
2/19/2026